CoChat

Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states

Open access
Prudencio, Mercedes, Borchelt, David R · 2011 · Molecular Neurodegeneration

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Mutations in superoxide dismutase 1 (SOD1), which are one cause of familial amyotrophic lateral sclerosis (fALS), induce misfolding and aggregation of the protein. Misfolding can be detected by the binding of antibodies raised against peptide epitopes that are normally buried in the native conformation, shifts in solubility in non-ionic detergents, and the formation of macromolecular inclusions. In the present study, we investigate the relationship between detergent-insoluble and sedimentable forms of mutant SOD1, forms of mutant SOD1 with aberrantly accessible epitopes, and mutant protein in inclusions with the goal of defining the spectrum of misfolded states that mutant SOD1 can adopt. RESULTS: Using combined approaches in cultured cell models, we demonstrate that a substantial fraction of mutant SOD1 adopts a non-native conformation that remains soluble and freely mobile. We also show that mutant SOD1 can produce multimeric assemblies of which some are insoluble in detergent and large enough to sediment by ultracentrifugation and some are large enough to detect visually. Three conformationally restricted antibodies were found to be useful in discriminating mal-folded forms of mutant SOD1. An antibody termed C4F6 displays properties consistent with recognition of soluble, freely mobile, mal-folded mutant SOD1. An antibody termed SEDI, which recognizes C-terminal residues, detects larger inclusion structures as well as soluble misfolded entities. An antibody termed hSOD1, which recognizes aa 24-36, detects an epitope shared by soluble non-natively folded WT and mutant SOD1. This epitope becomes inaccessible in aggregates of mutant SOD1. CONCLUSIONS: Our studies demonstrate how different methods of detecting misfolding and aggregation of mutant SOD1 reveal different forms of aberrantly folded protein. Immunological and biochemical methods can be used in combination to detect soluble and insoluble misfolded forms of mutant SOD1. Our findings support the view that mutant SOD1 can adopt multiple misfolded conformations with the potential that different structural variants mediate different aspects of fALS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1750-1326-6-77

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 HEK293FT cells expressing mutant SOD1 proteins do not form visible cellular inclusions. A-I) Cells were cultured on glass coverslips previously coated with 0.5 mg/ml poly-L-lysine untransfected (A, B), or transfected with expression plasmids for WT (C, D) or A4V (E, F) SOD1 for 24 hours. Fixed cells were stained with hSOD1 antibody overnight. A secondary fluorescent (594 nm) antibody was used to visualize SOD1 antibody binding. Co-staining with 4',6-diamidino-2-phenylindole (DAPI) was performed together with secondary antibody incubations. Pictures were taken with a 100× immersion oil objective, scale bar = 20 μm. Note that at the same exposure, the staining of overexpressed hSOD1 protein is much brighter than that of untransfected cells (compare figure A to C and E). The images shown are representative of at least 3 independent transfection experiments.
Figure 1 HEK293FT cells expressing mutant SOD1 proteins do not form visible cellular inclusions. A-I) Cells were cultured on glass coverslips previously coated with 0.5 mg/ml poly-L-lysine untransfected (A, B), or transfected with expression plasmids for WT (C, D) or A4V (E, F) SOD1 for 24 hours. Fixed cells were stained with hSOD1 antibody overnight. A secondary fluorescent (594 nm) antibody was used to visualize SOD1 antibody binding. Co-staining with 4',6-diamidino-2-phenylindole (DAPI) was performed together with secondary antibody incubations. Pictures were taken with a 100× immersion oil objective, scale bar = 20 μm. Note that at the same exposure, the staining of overexpressed hSOD1 protein is much brighter than that of untransfected cells (compare figure A to C and E). The images shown are representative of at least 3 independent transfection experiments.CC BY · PubMed Central
Figure 2 SEDI and C4F6 antibodies recognize diffusely distributed cytosolic mutant SOD1 in transiently transfected HEK293FT cells. Cells were transiently transfected with expression plasmids for WT (A-D) or A4V (E-H) SOD1 for 24 hours and stained with SEDI or C4F6 antibodies as explained in Methods. Pictures were taken with a 40× objective. Scale bars = 20 μm. Inset, image of rare cell with inclusion like structures. The images shown are representative of at least 3 independent transfection experiments.
Figure 2 SEDI and C4F6 antibodies recognize diffusely distributed cytosolic mutant SOD1 in transiently transfected HEK293FT cells. Cells were transiently transfected with expression plasmids for WT (A-D) or A4V (E-H) SOD1 for 24 hours and stained with SEDI or C4F6 antibodies as explained in Methods. Pictures were taken with a 40× objective. Scale bars = 20 μm. Inset, image of rare cell with inclusion like structures. The images shown are representative of at least 3 independent transfection experiments.CC BY · PubMed Central
Figure 3 Mutant SOD::YFP proteins form visible inclusions in cell culture. A) HEK293FT cells, on poly-L-lysine coated glass coverslips, were transfected for 24 hours as described in Methods. Cells were fixed and observed under a fluorescence microscope. All pictures were taken using a 40x objective, scale bars = 50 μm. The images shown are representative of at least 3 independent transfections for each construct. B) Immunoblot of P2 and S1 protein fractions of cells expressing SOD1::YFP proteins for 24 hours. The SOD1::YFP protein migrates at a size of approximately 50 kDa (filled arrowhead), while endogenous WT SOD1 monomer runs at 16 kDa (open arrowhead). C) Quantification of the aggregation propensity (P2/S1) of cells expressing SOD1::YFP proteins (see Methods). As expected, cells transfected with WT::YFP or mutant SOD1::YFP accumulated much more insoluble protein than untransfected cells: *p ≤ 0.05; #p ≤ 0.005. The aggregation propensity of A4V::YFP and G37R::YFP were both statistically greater than that of WT::YFP (#p ≤ 0.005). The data were averaged from at least 3 independent repetitions of each transfection and immunoblot.
Figure 3 Mutant SOD::YFP proteins form visible inclusions in cell culture. A) HEK293FT cells, on poly-L-lysine coated glass coverslips, were transfected for 24 hours as described in Methods. Cells were fixed and observed under a fluorescence microscope. All pictures were taken using a 40x objective, scale bars = 50 μm. The images shown are representative of at least 3 independent transfections for each construct. B) Immunoblot of P2 and S1 protein fractions of cells expressing SOD1::YFP proteins for 24 hours. The SOD1::YFP protein migrates at a size of approximately 50 kDa (filled arrowhead), while endogenous WT SOD1 monomer runs at 16 kDa (open arrowhead). C) Quantification of the aggregation propensity (P2/S1) of cells expressing SOD1::YFP proteins (see Methods). As expected, cells transfected with WT::YFP or mutant SOD1::YFP accumulated much more insoluble protein than untransfected cells: *p ≤ 0.05; #p ≤ 0.005. The aggregation propensity of A4V::YFP and G37R::YFP were both statistically greater than that of WT::YFP (#p ≤ 0.005). The data were averaged from at least 3 independent repetitions of each transfection and immunoblot.CC BY · PubMed Central
Figure 4 Analysis of detergent solubility and inclusion formation in cells co-expressing WT and mutant SOD1. HEK293FT were transfected with the indicated SOD1 constructs for 24 (A, B, E, G) or 48 (C, D, F, H) hours as noted above the figure. A, C) Immunoblots of P2 and S1 fractions of HEK293FT cells co-transfected with the indicated SOD1 constructs for 24 (A) or 48 (C) hours and immunoblotted with a SOD1 antibody. Tagged SOD1::YFP proteins migrate on SDS-PAGE at relative molecular mass of 50 kDa, while untagged SOD1 variants migrate at about 16 kDa. B, D) Quantification of the aggregation propensities (P2/S1) of tagged and untagged proteins from singly or doubly transfected cells at 24 (B) and 48 (D) hours. Statistical comparisons were calculated through unpaired student t-tests, *p ≤ 0.05, #p ≤ 0.005. The data were averaged from at least 3 independent transfection and immunoblotting experiments. E-H) Cells transfected for 24 (E, G) or 48 hours (F, H) were fixed and visualized under a confocal microscope. Scale bars = 20 μm. The images shown are representative of at least 3 independent transfection experiments.
Figure 4 Analysis of detergent solubility and inclusion formation in cells co-expressing WT and mutant SOD1. HEK293FT were transfected with the indicated SOD1 constructs for 24 (A, B, E, G) or 48 (C, D, F, H) hours as noted above the figure. A, C) Immunoblots of P2 and S1 fractions of HEK293FT cells co-transfected with the indicated SOD1 constructs for 24 (A) or 48 (C) hours and immunoblotted with a SOD1 antibody. Tagged SOD1::YFP proteins migrate on SDS-PAGE at relative molecular mass of 50 kDa, while untagged SOD1 variants migrate at about 16 kDa. B, D) Quantification of the aggregation propensities (P2/S1) of tagged and untagged proteins from singly or doubly transfected cells at 24 (B) and 48 (D) hours. Statistical comparisons were calculated through unpaired student t-tests, *p ≤ 0.05, #p ≤ 0.005. The data were averaged from at least 3 independent transfection and immunoblotting experiments. E-H) Cells transfected for 24 (E, G) or 48 hours (F, H) were fixed and visualized under a confocal microscope. Scale bars = 20 μm. The images shown are representative of at least 3 independent transfection experiments.CC BY · PubMed Central
Figure 5 Immunostaining of cells expressing SOD1::YFP fusion proteins with conformationally restricted SOD1 antibodies. HEK293FT were transfected with WT::YFP or A4V::YFP constructs, as noted on the Figure, and stained with hSOD1 (A-F), SEDI (G-L) or C4F6 (M-R) antibodies as explained in Methods. Pictures were taken using a 60× water immersion objective of a spinning disc confocal microscope, scale bars = 10 μm. Arrows indicate the location of SOD1::YFP inclusions and the absence of antibody staining. The images shown are representative of at least 3 independent transfection experiments.
Figure 5 Immunostaining of cells expressing SOD1::YFP fusion proteins with conformationally restricted SOD1 antibodies. HEK293FT were transfected with WT::YFP or A4V::YFP constructs, as noted on the Figure, and stained with hSOD1 (A-F), SEDI (G-L) or C4F6 (M-R) antibodies as explained in Methods. Pictures were taken using a 60× water immersion objective of a spinning disc confocal microscope, scale bars = 10 μm. Arrows indicate the location of SOD1::YFP inclusions and the absence of antibody staining. The images shown are representative of at least 3 independent transfection experiments.CC BY · PubMed Central
Figure 6 Inclusions formed by mutant SOD1::YFP proteins are not released by saponin treatment. CHO cells were transiently transfected with expression plasmids for YFP, WT::YFP, and A4V::YFP as noted in the figure and then, after 24 hours, treated with saponin, fixed in 4% paraformaldehyde, stained with DAPI, and imaged. A, B, E, F, I, J, M, N, Q, R, and S were not treated with saponin. C, D, G, H, K, L, O, P, and T were treated with saponin. Scale bars in A-L are 50 μm. The images in M-T are digitally magnified cells from A-L. Because saponin completely extracted all cyotosolic fluorescence from cell expressing WT::YFP, no digital magnifications of these cells are shown. The images shown are representative of at least 3 independent transfection experiments. Scale bar = 50 μm. Images were capture on a standard fluorescence microscope.
Figure 6 Inclusions formed by mutant SOD1::YFP proteins are not released by saponin treatment. CHO cells were transiently transfected with expression plasmids for YFP, WT::YFP, and A4V::YFP as noted in the figure and then, after 24 hours, treated with saponin, fixed in 4% paraformaldehyde, stained with DAPI, and imaged. A, B, E, F, I, J, M, N, Q, R, and S were not treated with saponin. C, D, G, H, K, L, O, P, and T were treated with saponin. Scale bars in A-L are 50 μm. The images in M-T are digitally magnified cells from A-L. Because saponin completely extracted all cyotosolic fluorescence from cell expressing WT::YFP, no digital magnifications of these cells are shown. The images shown are representative of at least 3 independent transfection experiments. Scale bar = 50 μm. Images were capture on a standard fluorescence microscope.CC BY · PubMed Central
Figure 7 Saponin treatment extracts cytosolic SOD1 immunostaining. HEK293FT cells were transfected with vectors for WT (A, B) or A4V SOD1 (C, D) and after 24 hours treated with saponin for 30 minutes at a concentration of 0.01% in 1× PBS. The cells were then fixed and immunostained as explained in Methods. Images were captured on a standard fluorescence microscope with an immersion oil 100× objective. All bars represent 20 μm. The images shown are representative of at least 3 independent transfection experiments.
Figure 7 Saponin treatment extracts cytosolic SOD1 immunostaining. HEK293FT cells were transfected with vectors for WT (A, B) or A4V SOD1 (C, D) and after 24 hours treated with saponin for 30 minutes at a concentration of 0.01% in 1× PBS. The cells were then fixed and immunostained as explained in Methods. Images were captured on a standard fluorescence microscope with an immersion oil 100× objective. All bars represent 20 μm. The images shown are representative of at least 3 independent transfection experiments.CC BY · PubMed Central
Figure 8 Detergent-insoluble forms of mutant SOD1 remain cell associated after saponin treatment. A) Immunoblots of HEK293FT cells that were transfected with the indicated SOD1 constructs for 48 hours. Prior to harvest, cells were incubated 30 minutes in PBS with 0.01% saponin. The harvested cell pellets were analyzed by detergent extraction and centrifugation assays (S1 fractions, each lane contains 5 μg of total protein; P2 fractions, each lane contains 20 μg of total protein). The amount of SOD1 protein released into the cell media was also evaluated (each lane loaded with 5 μg of total protein). B) Quantification of SOD1 protein found in the Media, P2 and S1 fractions of cells untreated or treated with saponin (Sap.), and expressing WT or A4V. Symbols over bars indicate differences from corresponding non-treated control. Unpaired t-tests: *p ≤ 0.05. The data were averaged from at least 3 independent transfection and immunoblotting experiments.
Figure 8 Detergent-insoluble forms of mutant SOD1 remain cell associated after saponin treatment. A) Immunoblots of HEK293FT cells that were transfected with the indicated SOD1 constructs for 48 hours. Prior to harvest, cells were incubated 30 minutes in PBS with 0.01% saponin. The harvested cell pellets were analyzed by detergent extraction and centrifugation assays (S1 fractions, each lane contains 5 μg of total protein; P2 fractions, each lane contains 20 μg of total protein). The amount of SOD1 protein released into the cell media was also evaluated (each lane loaded with 5 μg of total protein). B) Quantification of SOD1 protein found in the Media, P2 and S1 fractions of cells untreated or treated with saponin (Sap.), and expressing WT or A4V. Symbols over bars indicate differences from corresponding non-treated control. Unpaired t-tests: *p ≤ 0.05. The data were averaged from at least 3 independent transfection and immunoblotting experiments.CC BY · PubMed Central
Figure 9 The SEDI antibody recognizes immobile punctate structures in cells expressing A4V hSOD1. HEK293FT cells were transiently transfected with expression plasmids for either WT (A-D) or A4V (E-L) hSOD1 for 24 hours and stained with the SEDI or C4F6 antibody as explained in Methods. Pictures were taken with a 40x objective. Scale bars = 10 μm. The images in I-L were digitally magnified from A4V SOD1 cells stained with SEDI/DAPI. The images shown are representative of at least 3 independent transfection experiments.
Figure 9 The SEDI antibody recognizes immobile punctate structures in cells expressing A4V hSOD1. HEK293FT cells were transiently transfected with expression plasmids for either WT (A-D) or A4V (E-L) hSOD1 for 24 hours and stained with the SEDI or C4F6 antibody as explained in Methods. Pictures were taken with a 40x objective. Scale bars = 10 μm. The images in I-L were digitally magnified from A4V SOD1 cells stained with SEDI/DAPI. The images shown are representative of at least 3 independent transfection experiments.CC BY · PubMed Central
Figure 10 CHO cells expressing A4V::YFP SOD1 fusion protein do not show evidence of increased membrane permeability. To assess whether aggregates of mutant SOD::YFP fusion proteins induce cell death, CHO cells were transiently transfected with expression vectors for SOD1 A4V::YFP (A and B) and WT::YFP (C). After 48 hours, the cells were incubated with dimeric ethidium bromide (EtBr) as described in Methods. Images were captured at 40× magnification (scale bar = 50 μm). Overall, there were few cells that showed evidence of increase membrane permeability with no obvious difference between cultures transfected with the 2 constructs or untransfected cells (D). As a positive control, untransfected cells were treated with staurosporine (+Str) to induce death and stained with dimeric ethidium bromide (D).
Figure 10 CHO cells expressing A4V::YFP SOD1 fusion protein do not show evidence of increased membrane permeability. To assess whether aggregates of mutant SOD::YFP fusion proteins induce cell death, CHO cells were transiently transfected with expression vectors for SOD1 A4V::YFP (A and B) and WT::YFP (C). After 48 hours, the cells were incubated with dimeric ethidium bromide (EtBr) as described in Methods. Images were captured at 40× magnification (scale bar = 50 μm). Overall, there were few cells that showed evidence of increase membrane permeability with no obvious difference between cultures transfected with the 2 constructs or untransfected cells (D). As a positive control, untransfected cells were treated with staurosporine (+Str) to induce death and stained with dimeric ethidium bromide (D).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 72

Metadata

Authors
Prudencio, M., & Borchelt, D. R.
Affiliations
University of Florida (US)
Corresponding author
Borchelt, David R
Venue
Molecular Neurodegeneration
Published
2011
Volume
6
Issue
1
Pages
77
ISSN
1750-1326 (ISSN-L)
OpenAlex
W2107672209
Cited by
63
References
56
Citations by year
2026: 3 · 2025: 4 · 2024: 2 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 4 · 2015: 2 · 2014: 13 · 2013: 13 · 2012: 6
FWCI
6.43
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Institute of Neurological Disorders and Stroke (P01NS049134)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Keywords
superoxide dismutase 1, SOD1 mutations, familial ALS, protein misfolding, protein aggregation, epitope accessibility
MeSH terms
Superoxide Dismutase-1, Amyotrophic Lateral Sclerosis, Animals, Antibodies, Cricetulus, Disease Models, Animal, Cricetinae, Humans, Mice, Transgenic, Mutation, Protein Conformation, Recombinant Fusion Proteins, Superoxide Dismutase, CHO Cells, Protein Folding, Mutant Proteins, Mice, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. https://app.cochat.ai/papers/10.1186/1750-1326-6-77
The paper
Prudencio, M., & Borchelt, D. R. (2011). Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. Molecular Neurodegeneration. https://doi.org/10.1186/1750-1326-6-77

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.